临床医生对孕期先进基因组检测中父母选择权的态度
多数参与者支持在披露不确定遗传信息时给予父母选择权,但所有受访者均认为对于医学上可干预的成人起病疾病,披露获益大于损害。
要点
- 多数受访医护人员支持让父母参与不确定遗传信息的披露决策。
- 医护人员认为充分准备后父母能做出知情决策。
- 所有受访者同意医学上可干预的成人起病疾病应披露。
核心结论
- 医护人员态度总体上与以色列让父母参与不确定信息披露决策的实践一致。
- 这或可缓解披露困境,并允许基于父母观点进行个性化披露。
主要发现
- 多数参与者(24名)支持对不确定遗传信息给予父母选择权。
- 让父母参与披露决策可避免潜在焦虑信息、实践父母自主权并为不确定结果做好准备。
- 4名参与者认为披露应基于专业判断,1名支持完全披露。
- 所有受访者一致认为,对于医学上可干预的成人起病疾病,披露获益大于损害。
临床怎么用
- 临床中可让父母参与不确定遗传信息(如意义不明变异、易感位点)的披露决策。
- 对于医学上可干预的成人起病疾病,应基于获益大于损害的原则进行披露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Israel is one of the first countries to incorporate chromosomal microarray analysis into routine prenatal care. We explored attitudes of Israeli healthcare professionals (HCPs) towards the disclosure of challenging findings: variants of uncertain clinical significance (VUS), susceptibility loci (SL) for neurodevelopmental disorders and variants associated with adult-onset (AO) conditions. Particularly, we sought their views on providing parental choice regarding the disclosure of these findings. METHODS: Twenty-nine in-depth interviews were conducted with genetic counselors (n = 19), medical geneticists (n = 4), medical geneticists that are trained in and practice fetal medicine (n = 3), and fetal medicine experts (n = 3). RESULTS: Most participants (n = 24) supported parental choice regarding uncertain genetic information. Engaging parents in disclosure decisions allows avoidance from potentially anxiety-provoking information, practicing parental autonomy, and better preparation in cases where uncertain findings are identified. HCPs believed that given appropriate preparation, parents can make informed decisions. Four participants believed that disclosure should be based on professional judgment and one supported full-disclosure. Unlike VUS or SL, all interviewees agreed that in cases of medically actionable AO conditions, the benefit of disclosure outweighs the damage. CONCLUSION: HCPs attitudes are largely in-line with the Israeli practice of involving parents in disclosure decisions regarding uncertain information. This may mitigate disclosure dilemmas and allow personalized disclosure based on parents' views.
引用
- Macarov M, Meiner V, Chalk M, et al. Clinicians' attitudes towards parental choice in the era of advanced genomic tests in pregnancy. Prenat Diagn. 2021. PMID: 34259341. doi:10.1002/pd.6010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。